Gl
Non verificato

Glaukos Corporation

Di cosa scriviamo

Attrezzature medico-sanitarieFarmaceuticaOtticaSaluteWeb e Social Network
16/04/2026
Salute
Farmaceutica
Medicina - Varie
Associazioni/Professionisti
Ottica
Ecologia/Salute ambientale
Scienza
Attrezzature medico-sanitarie
Glaukos Announces the Release of its 2025 Sustainability Report
1.00
15/04/2026
Industria
Medicina - Varie
HIV, AIDS e malattie autoimmuni
Igiene alimentare
Salute
Farmaceutica
Sanità
Ottica
Glaukos Receives Permanent J-code for Epioxa™
1.00
08/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Medicina - Varie
Salute
Farmaceutica
Ottica
Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29
1.00
17/02/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Medicina - Varie
Salute
Farmaceutica
Ottica
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
1.00
28/01/2026
Igiene alimentare
Salute
Farmaceutica
Ottica
Industria
Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR
1.00
20/01/2026
Farmaceutica
Ottica
Salute
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
1.00
13/01/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Attrezzature medico-sanitarie
Salute
Farmaceutica
Ottica
Biotecnologia
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
1.00
16/12/2025
Eventi
Web e Social Network
Farmaceutica
Ottica
Salute
Attrezzature medico-sanitarie
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
1.00
03/11/2025
Farmaceutica
Ottica
Salute
Attrezzature medico-sanitarie
Eventi
Web e Social Network
Glaukos Announces Participation in Upcoming Investor Conferences
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0